BioLineRx
(NASDAQ) BLRX
BioLineRx Financials at a Glance
Market Cap
$11.79M
Revenue (TTM)
$12.73M
Net Income (TTM)
$2.98M
EPS (TTM)
$-1.37
P/E Ratio
-1.97
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Price
$2.73
Volume
1,546.65
Open
$2.54
Price
$2.73
Volume
1,546.65
Open
$2.54
Previous Close
$2.71
Daily Range
$2.54 - $2.69
52-Week Range
$2.30 - $7.77
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Price
$2.73
Volume
1,546.65
Open
$2.54
Previous Close
$2.71
Daily Range
$2.54 - $2.69
52-Week Range
$2.30 - $7.77
BLRX News
BLRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioLineRx
Industry
Biotechnology
Sector
Health CareEmployees
28
CEO
Philip Adam Serlin, MBA, CPA
Website
www.biolinerx.comHeadquarters
Hevel Modi'in, 7177871, IL
BLRX Financials
Key Financial Metrics (TTM)
Gross Margin
51%
Operating Margin
-89%
Net Income Margin
-23%
Return on Equity
-22%
Return on Capital
-43%
Return on Assets
-7%
Earnings Yield
-50.76%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$11.79M
Shares Outstanding
4.35M
Volume
1.55K
Short Interest
0.00%
Avg. Volume
15.62K
Financials (TTM)
Gross Profit
$19.68M
Operating Income
$20.41M
EBITDA
$3.92M
Operating Cash Flow
$43.87M
Capital Expenditure
$54.00K
Free Cash Flow
$43.93M
Cash & ST Invst.
$19.56M
Total Debt
$15.04M
BioLineRx Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$427.00K
-91.4%
Gross Profit
$343.00K
-91.7%
Gross Margin
80.33%
N/A
Market Cap
$11.79M
N/A
Market Cap/Employee
$421.05K
N/A
Employees
28
N/A
Net Income
$977.00K
+83.2%
EBITDA
$554.00K
+83.5%
Quarterly Fundamentals
Net Cash
$13.83M
+3237.0%
Accounts Receivable
$699.00K
-82.4%
Inventory
$2.18M
-38.5%
Long Term Debt
$6.60M
-65.7%
Short Term Debt
$4.78M
-53.8%
Return on Assets
-7.48%
N/A
Return on Invested Capital
-43.34%
N/A
Free Cash Flow
$2.11M
+78.6%
Operating Cash Flow
$2.11M
+78.6%